Business
Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute
LAVAL, QC / ACCESSWIRE / January 8, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), and...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent DisputeLAVAL, QC / ACCESSWIRE / January 8, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, as scheduled, oral arguments were heard today at the U.S. Court of Appeals for the Federal Circuit (the \"Court\") in the matter of Salix Pharmaceuticals, LTD et al v. Norwich Pharmaceuticals, Inc. As expected, no ruling was issued by the Court following these oral arguments.\"We were pleased to have had the opportunity to present our oral arguments to the Court of Appeals today,\" Thomas J. Appio, Chief Executive Officer said. \"We look forward to the Court's decision in due course. We will continue to advocate for the safety of patients who have benefited from continued access to XIFAXAN, and look forward to continuing to serve those patients.\"About XIFAXANXIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.About SalixSalix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases. For more than 30 years, Salix has licensed, developed and marketed innovative products to improve patients' lives and arm health care providers with life-changing solutions for many chronic and debilitating conditions. Salix currently markets its product line to U.S. health care providers through an expanded sales force that focuses on gastroenterology, hepatology, pain specialists and primary care. Salix is headquartered in Bridgewater, New Jersey. For more information about Salix, visit www.Salix.com and connect with us on Twitter and LinkedIn.About Bausch HealthBausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our controlling ownership interest of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as ...